Please assess the completion status of the following clinical trial:

Trial Title: Effect of Intravenous Ceftriaxone and Oral Doxycycline for Lyme Neuroborreliosis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Neurological symptoms and/or findings consistent with neuroborreliosis and at least one of the following fulfilled:~  * Intrathecal production of borrelia antibodies;~ * White cell count in cerebrospinal fluid (CSF) \> 5/mm3;~ * Significant rise in borrelia antibodies in two serum samples collected from a patient with at least 3 weeks interval;~ * Verified acrodermatitis chronica atrophicans.~Exclusion Criteria:~* Allergy to the contents in the medication, or earlier type I reaction to penicillin.~* Treatment with cephalosporins, penicillin or tetracyclins during the last 14 days~* Pregnancy or breastfeeding~* Age \< 18 years

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 100 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Doxycycline
- 2 (Type: ACTIVE_COMPARATOR): cephtriaxone

Based on this trial design, predict the completion outcome and termination type (if applicable).